Medicinal Products Manufactured by Fresenius Kabi
- Prescription pharmaceuticals
- Hospital pharmaceuticals
- Non-registered pharmaceuticals
- Parenteral nutrition
- Fluid and volume replacement therapy
Antibacterials for systemic use
Carbapenems, fluoroquinolones, cephalosporins, antistaphylococcal penicillins, combinations of penicillins with beta-lactamase inhibitors, other aminoglycosides, other anti-infectives.
Alkyl sulfonates, alkylating agents, taxanes, topoisomerase 1 inhibitors, pyrimidine analogues, folic acid analogues, podophyllotoxin derivatives, platinum compounds.
Drugs for treatment of bone diseases
Bisphosphonates (also diphosphonates) are a group of active substances that inhibit osteoclastic activity and thus bone resorption (breakdown). They are used in the prevention and treatment of osteoporosis, Paget's disease of bone, bone metastases, multiple plasmacytomas and other bone diseases that cause bone fragility.
Acetic acid derivatives, other analgesics and antipyretics, local anaesthetics, general anaesthetics.
Immunosuppressants – biosimilars
Adalimumab is a human monoclonal antibody biologic that binds and inactivates TNF-alpha. It is used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa and uveitis.
The main physiological function of vitamin D is to increase the ability of the small intestine to absorb calcium and phosphorus, thereby maintaining adequate blood levels of calcium and phosphorus. This allows normal bone mineralisation, affects skin cell differentiation, regulates the activity of immune system cells and affects the transmission of hormone-sensitive genes, which regulates the production of many proteins. It should be noted that vitamin D's important role in maintaining healthy bones can only be ensured if an adequate intake of calcium is provided in addition to an adequate intake of vitamin D.